Authors : Lunjapikai Haokip; Kuppa Vagdevi; Annette Angel; Bennet Angel; Vinod Joshi; Monika Dheer; Prigya Sharma

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/43496c7w

Scribd : https://tinyurl.com/2ypssvsc

DOI : https://doi.org/10.38124/ijisrt/25jul992

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : The reported study has been undertaken to validate a molecular assay for isolation of key EBV proteins in clinical samples of saliva in suspected cases by employing laboratory techniques, namely Polymerase Chain Reaction (PCR) and Agarose Gel Electrophoresis (AGE), etc. BamHI Z fragment leftward open reading frame 1 (BZLF1), BCLF1 (major capsid protein) or BC1, and Epstein-Barr nuclear antigen 1 (EBNA1) were selected as target genes due to their role in the viral replication cycle, latency, oncogenesis, and lytic reactivation. BZLF1 is an immediate-early viral gene, also known as Zta, EB1, or ZEBRA. It is frequently used for the detection of EBV as it is a conserved gene. It plays an important role in converting the EBV from the latent to lytic stage and further leading to viral replication. This is the most studied gene. BCLF1 is a late gene involved in the formation of structural proteins, specifically the major capsid protein, in association with other genes like BFRF3, BDLF1, and BORF1. EBNA1 is a latent gene responsible for the virus's replication, maintenance in infected cells, and evasion from the immune system. All three genes are very important in EBV-related malignancies. The molecular assay was carried out in 11 samples of suspected EBV cases, which showed the presence of at least one of the EBV proteins in all the samples. The BZLF1 gene was most prevalent, as 6 out of 11 samples were found positive for this gene, followed by the BCLF1 gene positive in 5 samples. EBNA1 protein was present only in 2 samples. The results showed good diagnostic utility of PCR to detect EBV genes.

Keywords : EBV; Oral Carcinoma; EBV Genes; Malignancies; Molecular Assay; Viral Replication; PCR.

References :

1. R. J. Abbott et al., “Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases,” J. Virol., vol. 91, no. 21, pp. e00382-17, Oct. 2017, doi: 10.1128/JVI.00382-17.
2. A. L. Adamson et al., “Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases,” J. Virol., vol. 74, no. 3, pp. 1224–1233, Feb. 2000, doi: 10.1128/jvi.74.3.1224-1233.2000.
3. M. A. H. Abusalah, S. H. Gan, M. A. I. Al-Hatamleh, A. A. Irekeola, R. H. Shueb, and C. Yean Yean, “Recent Advances in Diagnostic Approaches for Epstein–Barr Virus,” Pathogens, vol. 9, no. 3, p. 226, Mar. 2020, doi: 10.3390/pathogens9030226.
4. K. Vrzalikova, T. Sunmonu, G. Reynolds, and P. Murray, “Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma,” Pathog. Basel Switz., vol. 7, no. 3, p. 59, Jun. 2018, doi: 10.3390/pathogens7030059.
5. P. T. Naing, A. Kaur, and D. T. Lynch, “Burkitt Lymphoma,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Jul. 17, 2025. [Online].Available:http://www.ncbi.nlm.nih.gov/books/NBK538148/
6. H. Samant, P. Vaitla, and J. P. Kothadia, “Posttransplant Lymphoproliferative Disorders,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Jul. 17, 2025. [Online]. Available:http://www.ncbi.nlm.nih.gov/books/NBK513249/